Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT6 Agents with a Beneficial Neuroprotective Profile against Alzheimer’s Disease
Patryk Pyka, Wawrzyniec Haberek, Małgorzata Więcek, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 1580-1610
Open Access | Times Cited: 12

Showing 12 citing articles:

Selenium-containing compounds: a new hope for innovative treatments in Alzheimer’s disease and Parkinson’s disease
Patryk Pyka, Sabrina Garbo, Rossella Fioravanti, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104062-104062
Open Access | Times Cited: 7
Discovery of Selenium-Containing Derivatives as Potent and Orally Bioavailable GLP-1R Agonists
Xuetao Chen, Shicheng Xu, Shuang Yang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Procognitive Potential of Neuroprotective Triazine 5-HT6 Receptor Antagonists Tested on Chronic Activity In Vivo in Rats: Computer-Aided Insight into the Role of Chalcogen-Differences on the Pharmacological Profile
Magdalena Jastrzębska‐Więsek, Sabrina Garbo, Agnieszka Cios, et al.
ACS Chemical Neuroscience (2025)
Open Access
Discovery of new dual butyrylcholinesterase (BuChE) inhibitors and 5-HT7 receptor antagonists as compounds used to treat Alzheimer’s disease symptoms
Damian Kułaga, Anna K. Drabczyk, Przemysław Zaręba, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 117995-117995
Closed Access
5-HT6 receptor neutral antagonists protect astrocytes: A lesson from 2-phenylpyrrole derivatives
Marcin Drop, Paulina Koczurkiewicz, Ophélie Bento, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116615-116615
Open Access | Times Cited: 2
Dual 5-HT6/SERT ligands for mitigating neuropsychiatric symptoms of dementia exerting neuroprotection against amyloid-β toxicity, memory preservation, and antidepressant-like properties
Agata Siwek, Monika Marcinkowska, Monika Głuch‐Lutwin, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116601-116601
Closed Access | Times Cited: 1
Pharmacokinetics and Enterohepatic Circulation of 2-(Quinoline-8-carboxamido)benzoic Acid (2-QBA) in Mice
Jihyeon Jeon, Soyeon Jeon, Yeon-Ju Baek, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 934-934
Open Access | Times Cited: 1
Unlocking the potential of higher-molecular-weight 5-HT7R ligands: Synthesis, affinity, and ADMET examination
Patryk Pyka, Sabrina Garbo, Aleksandra Murzyn, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107668-107668
Open Access | Times Cited: 1
Selenium: The Emerging Element in the Medicinal Chemist’s Toolkit
Lanmeng Cui, Wei Hou, Hongtao Xu
Future Medicinal Chemistry (2024) Vol. 16, Iss. 6, pp. 493-496
Closed Access
Selenium(II)‐Nitrogen Exchange (SeNEx) Chemistry: A Good Chemistry Suitable for Nanomole‐Scale Parallel Synthesis, DNA‐encoded Library Synthesis, and Bioconjugation
Wei Hou, Shaoneng Hou, Yuang Gu, et al.
ChemBioChem (2024)
Closed Access
Evaluation of isatin-1,3,5-triazine-benzylamine hybrids as multi-target directed ligands against Alzheimer's disease
Yasaman Tamaddon-Abibigloo, Siavoush Dastmalchi, Nima Razzaghi‐Asl, et al.
Journal of Molecular Structure (2024), pp. 140717-140717
Closed Access
Organoselenium compounds beyond antioxidants
Ritu Mamgain, Garima Mishra, Saumya Kriti, et al.
Future Medicinal Chemistry (2024), pp. 1-23
Closed Access
Page 1

Scroll to top